Medtronic profit more than doubles on recovery in base business

Tiger Newspress2021-05-27

Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year 2021, which endedApril 30, 2021.

- Q4 Revenue of$8.2 Billion Increased 37% Reported and 32% Organic.

- Q4 GAAP Diluted EPS of$1.00; Q4 Non-GAAP Diluted EPS of$1.50.

-Net income attributable to the company rose to $1.36 billion, or $1 per share, in the quarter ended April 30, from $646 million, or 48 cents per share, a year earlier.

- Quarterly Dividend Increased to$0.63, Annual$2.52 from Prior$2.32; 44th Consecutive Year of Dividend Increases.

- Company Issues FY22 Guidance.

- Guidance Reflects FY22 Revenue Growth above Street Consensus, Investment Ahead of Major Product Launches, and Largest Planned R&D Increase in Company History.

Medtronic shares were unchanged in premarket trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
14